Lantronix CEO to Participate in Craig-Hallum, ROTH and Headgate Partners Investor Conferences

Stock Information for Erytech Pharma S.A.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Erytech Pharma S.A.

Lantronix Expands Presence in Global Drone and Defense Markets with Trillium Engineering Collaboration
Lantronix to Launch New Edge AI Solutions at CES 2026
Lantronix Founder Bernhard Bruscha Donates 3.0 million shares of Lantronix Common Stock to TL Stiftung (TL Foundation)
Lantronix Reports Fiscal First Quarter 2026 Financial Results
Lantronix Edge AI Technology Powers Sightline's New AI-Driven Video Processor for Mission-Critical Drone Applications
Lantronix to Report Fiscal 2026 First Quarter Results on Nov. 5, 2025
Lantronix Unveils Kompress.ai by Lantronix, an AI-Powered Platform That Optimizes Performance in Energy-Intensive Industries Using Vodafone IoT's Connectivity
Lantronix to Showcase Edge AI Drone Platform at AUSA 2025, Highlighting Strategic Partnerships and UAV Innovations

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.